We are live on ! Find out more
SN

Sittner & Nelson Portfolio holdings

AUM $274M
1-Year Est. Return 22.46%
This Fund
S&P 500
This Quarter Est. Return
+2.08%
1 Year Est. Return
+22.46%
3 Year Est. Return
+78.95%
5 Year Est. Return
+110.07%
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$7.09M
Cap. Flow
+$4.92M
Cap. Flow %
2.13%
Top 10 Hldgs %
48.94%
Holding
507
New
77
Increased
115
Reduced
52
Closed
15

Top Buys

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$1.7M
2
CGUS icon
Capital Group Core Equity ETF
CGUS
+$793K
3
ASML icon
ASML
ASML
+$560K
4
CGDV icon
Capital Group Dividend Value ETF
CGDV
+$546K
5
STX icon
Seagate
STX
+$479K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$307K
2
MPT
Medical Properties Trust
MPT
+$234K
3
JPM icon
JPMorgan Chase
JPM
+$217K
4
SUN icon
Sunoco
SUN
+$215K
5
GSK icon
GSK
GSK
+$187K

Sector Composition

Rank Sector Weight
1 Technology 28.39%
2 Financials 18.7%
3 Healthcare 9.25%
4 Industrials 7.71%
5 Consumer Discretionary 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
126
Unilever
UL
$137B
$206K 0.09%
3,236
+7
+0.2% +$473
ED icon
127
Consolidated Edison
ED
$40.1B
$204K 0.09%
2,281
+6
+0.3% +$591
ITOT icon
128
iShares Core S&P Total US Stock Market ETF
ITOT
$94.4B
$202K 0.09%
1,570
– –
KEYS icon
129
Keysight
KEYS
$54.5B
$196K 0.09%
1,222
– –
GRMN
130
Garmin
GRMN
$56.7B
$195K 0.08%
947
– –
VO icon
131
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$194K 0.08%
2,940
– –
BTI icon
132
British American Tobacco
BTI
$131B
$191K 0.08%
5,250
– –
BMRN icon
133
BioMarin Pharmaceuticals
BMRN
$11.6B
$191K 0.08%
2,900
– –
DE icon
134
Deere & Co
DE
$160B
$189K 0.08%
446
– –
EIX icon
135
Edison International
EIX
$28.2B
$184K 0.08%
2,300
-66
-3% -$5.52K
ADP icon
136
Automatic Data Processing
ADP
$106B
$183K 0.08%
625
– –
ZBH icon
137
Zimmer Biomet
ZBH
$18.2B
$183K 0.08%
1,732
-353
-17% -$37.9K
RVT icon
138
Royce Value Trust
RVT
$2.21B
$182K 0.08%
11,531
+324
+3% +$5.17K
EA icon
139
Electronic Arts
EA
$53B
$177K 0.08%
1,210
+100
+9% +$15.4K
GSK icon
140
GSK
GSK
$104B
$174K 0.08%
5,153
-5,200
-50% -$187K
CRSP icon
141
CRISPR Therapeutics
CRSP
$4.73B
$173K 0.07%
4,390
+653
+17% +$30.8K
XAR icon
142
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.93B
$172K 0.07%
1,040
– –
NTRA icon
143
Natera
NTRA
$38.3B
$158K 0.07%
1,000
– –
CNQ icon
144
Canadian Natural Resources
CNQ
$99.4B
$155K 0.07%
5,026
– –
FDX icon
145
FedEx
FDX
$72.7B
$141K 0.06%
502
– –
VXUS icon
146
Vanguard Total International Stock ETF
VXUS
$155B
$141K 0.06%
2,394
– –
CMCSA icon
147
Comcast
CMCSA
$85B
$141K 0.06%
3,759
-349
-8% -$14.5K
PSX icon
148
Phillips 66
PSX
$84.9B
$139K 0.06%
1,219
– –
D icon
149
Dominion Energy
D
$60.8B
$137K 0.06%
2,548
– –
CAH icon
150
Cardinal Health
CAH
$53.9B
$136K 0.06%
1,150
– –
4 5
6
7 8

Similar funds

MC
Mathes Company New York $274M AUM 33.72% 1-Year Est. Return
OL
Odyssean LLC Darien, Connecticut $274M AUM
JWM
Jessup Wealth Management Dayton, Ohio $274M AUM 29.44% 1-Year Est. Return
MP
Maestria Partners Atlanta, Georgia $274M AUM 13.12% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
AGP
Autumn Glory Partners Dallas, Texas $272M AUM 20.37% 1-Year Est. Return

Sittner & Nelson's Q4 2024 Portfolio in Review

As of Q4 2024, Sittner & Nelson held 507 positions worth $231M, up 3.2% from $224M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sittner & Nelson's Q4 2024 filing shows 77 new, 115 increased, 52 reduced and 15 closed positions. Its largest new stake was MAG Silver: 5,000 shares worth $68K. The largest sale was Pfizer, an estimated $307K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Sittner & Nelson's largest Q4 2024 buy was MAG Silver: 5,000 shares worth $68K.
  • Sittner & Nelson added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2024, an estimated $1.7M increase.
  • Sittner & Nelson's biggest Q4 2024 reduction was Pfizer, cutting an estimated $307K.
  • Sittner & Nelson fully exited Medical Properties Trust in Q4 2024, selling an estimated $234K.
  • Sittner & Nelson's ten largest holdings make up 49% of its $231M portfolio in Q4 2024.
  • Sittner & Nelson opened 77 new positions and closed 15 in Q4 2024.
  • Sittner & Nelson's portfolio value rose 3.2% quarter-over-quarter to $231M.

Based on Sittner & Nelson's 13F filing for Q4 2024, filed 11 Feb 2025.